Published in Materials (Basel) on May 18, 2016
Microbial biofilms. Annu Rev Microbiol (1995) 21.58
Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol (2004) 18.85
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev (1996) 13.25
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol (2007) 10.18
Biofilms: microbial life on surfaces. Emerg Infect Dis (2002) 7.57
Biofilms: the matrix revisited. Trends Microbiol (2005) 6.66
Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents (2010) 5.18
Cyclic di-GMP: the first 25 years of a universal bacterial second messenger. Microbiol Mol Biol Rev (2013) 4.69
Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest (1997) 4.62
Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci (2004) 4.60
Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis (2001) 3.84
D-amino acids trigger biofilm disassembly. Science (2010) 3.60
Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology (2003) 3.26
In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci (2005) 2.89
Biofilm dispersal in Xanthomonas campestris is controlled by cell-cell signaling and is required for full virulence to plants. Proc Natl Acad Sci U S A (2003) 2.85
Forging a link between biofilms and disease. Science (1999) 2.82
What drives bacteria to produce a biofilm? FEMS Microbiol Lett (2004) 2.59
Quorum sensing inhibitors: an overview. Biotechnol Adv (2012) 2.56
A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J Bacteriol (2008) 2.42
Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther (2013) 2.24
Iron salts perturb biofilm formation and disrupt existing biofilms of Pseudomonas aeruginosa. Chem Biol (2005) 2.13
Silver as antibacterial agent: ion, nanoparticle, and metal. Angew Chem Int Ed Engl (2012) 2.07
Trends and developments in liposome drug delivery systems. J Pharm Sci (2001) 2.06
In harm's way: infections in deployed American military forces. Clin Infect Dis (2006) 2.00
Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect (2007) 2.00
Multidrug resistant acinetobacter. J Glob Infect Dis (2010) 1.94
Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. J Bacteriol (2007) 1.80
Silver-nanoparticle-embedded antimicrobial paints based on vegetable oil. Nat Mater (2008) 1.78
Potential of silver nanoparticle-coated polyurethane foam as an antibacterial water filter. Biotechnol Bioeng (2005) 1.75
Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev (2011) 1.65
Antimicrobial activities of silver dressings: an in vitro comparison. J Med Microbiol (2006) 1.61
Matrices and scaffolds for protein delivery in tissue engineering. Adv Drug Deliv Rev (2007) 1.55
Biofilms can be dispersed by focusing the immune system on a common family of bacterial nucleoid-associated proteins. Mucosal Immunol (2011) 1.54
Alginate production by Pseudomonas putida creates a hydrated microenvironment and contributes to biofilm architecture and stress tolerance under water-limiting conditions. J Bacteriol (2007) 1.41
Acinetobacter infection--an emerging threat to human health. IUBMB Life (2011) 1.39
Monolayer coated gold nanoparticles for delivery applications. Adv Drug Deliv Rev (2011) 1.36
Inhibition and dispersion of Pseudomonas aeruginosa biofilms by glycopeptide dendrimers targeting the fucose-specific lectin LecB. Chem Biol (2008) 1.34
Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection. PLoS One (2012) 1.32
Pseudomonas aeruginosa PAO1 preferentially grows as aggregates in liquid batch cultures and disperses upon starvation. PLoS One (2009) 1.31
Two cases of necrotizing fasciitis due to Acinetobacter baumannii. J Clin Microbiol (2008) 1.30
Study of the response of a biofilm bacterial community to UV radiation. Appl Environ Microbiol (1999) 1.29
Antibacterial activities of gold and silver nanoparticles against Escherichia coli and bacillus Calmette-Guérin. J Nanobiotechnology (2012) 1.28
Isolation and characterization of phi AB2: a novel bacteriophage of Acinetobacter baumannii. Res Microbiol (2010) 1.27
Community-acquired Acinetobacter infections. Eur J Clin Microbiol Infect Dis (2007) 1.23
Murine immune response to a chronic Staphylococcus aureus biofilm infection. Infect Immun (2011) 1.21
Synthesis, optimization, and characterization of silver nanoparticles from Acinetobacter calcoaceticus and their enhanced antibacterial activity when combined with antibiotics. Int J Nanomedicine (2013) 1.21
Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters. FEMS Immunol Med Microbiol (2011) 1.20
Multi-drug resistant Acinetobacter infections in critically injured Canadian forces soldiers. BMC Infect Dis (2007) 1.19
The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli. Biomaterials (2011) 1.18
The use of nitric oxide releasing nanoparticles as a treatment against Acinetobacter baumannii in wound infections. Virulence (2010) 1.18
Cyclodextrins. Int J Pharm (2012) 1.17
Poly-N-acetyl-β-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections. Infect Immun (2011) 1.17
Synthesis of silver nanoparticles using Dioscorea bulbifera tuber extract and evaluation of its synergistic potential in combination with antimicrobial agents. Int J Nanomedicine (2012) 1.16
Emerging therapies for multidrug resistant Acinetobacter baumannii. Trends Microbiol (2013) 1.13
Photodynamic inactivation of Acinetobacter baumannii using phenothiazinium dyes: in vitro and in vivo studies. Lasers Surg Med (2010) 1.12
A study on nosocomial pathogens in ICU with special reference to multiresistant Acinetobacter baumannii harbouring multiple plasmids. Indian J Med Res (2008) 1.11
Similarities and differences in the responses of microorganisms to biocides. J Antimicrob Chemother (2003) 1.10
Silver-coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threat. ACS Nano (2012) 1.10
Species distribution and physiological characterization of Acinetobacter genospecies from healthy human skin of tribal population in India. Indian J Med Microbiol (2007) 1.06
Therapeutic platforms based on gold nanoparticles and their covalent conjugates with drug molecules. Adv Drug Deliv Rev (2012) 1.05
Review: development of clinically relevant scaffolds for vascularised bone tissue engineering. Biotechnol Adv (2012) 1.04
Antibacterial effect of silver nanoparticles on Staphylococcus aureus. Biometals (2010) 1.03
Anti-biofilm activity of silver nanoparticles against different microorganisms. Biofouling (2013) 0.99
Characterization of plant-growth-promoting traits of Acinetobacter species isolated from rhizosphere of Pennisetum glaucum. J Microbiol Biotechnol (2011) 0.99
Distribution and in vitro antimicrobial susceptibility of Acinetobacter species on the skin of healthy humans. Natl Med J India (2001) 0.99
Functional gold nanoparticles as photothermal agents for selective-killing of pathogenic bacteria. Nanomedicine (Lond) (2007) 0.98
Insights into acinetobacter war-wound infections, biofilms, and control. Adv Skin Wound Care (2010) 0.97
Bacteriagenic silver nanoparticles: synthesis, mechanism, and applications. Appl Microbiol Biotechnol (2015) 0.96
Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections. Infect Immun (2012) 0.96
Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap). Microb Pathog (2011) 0.96
Self-assembled monolayers of silver nanoparticles firmly grafted on glass surfaces: low Ag+ release for an efficient antibacterial activity. J Colloid Interface Sci (2010) 0.95
Characterization of eDNA from the clinical strain Acinetobacter baumannii AIIMS 7 and its role in biofilm formation. ScientificWorldJournal (2012) 0.95
Broad-spectrum antimicrobial and biofilm-disrupting hydrogels: stereocomplex-driven supramolecular assemblies. Angew Chem Int Ed Engl (2012) 0.94
Nitric oxide: a key mediator of biofilm dispersal with applications in infectious diseases. Curr Pharm Des (2015) 0.93
Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury. Surgery (2010) 0.92
The effect of silver or gallium doped titanium against the multidrug resistant Acinetobacter baumannii. Biomaterials (2015) 0.92
Biofilm formation on pyrolytic carbon heart valves: influence of surface free energy, roughness, and bacterial species. J Thorac Cardiovasc Surg (2007) 0.90
Rapid efficient synthesis and characterization of silver, gold, and bimetallic nanoparticles from the medicinal plant Plumbago zeylanica and their application in biofilm control. Int J Nanomedicine (2014) 0.89
Novel antibacterial nanofibrous PLLA scaffolds. J Control Release (2010) 0.89
Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis (2011) 0.89
Microbial synthesis of gold nanoparticles: current status and future prospects. Adv Colloid Interface Sci (2014) 0.89
Antimicrobial activity of nanoemulsion in combination with cetylpyridinium chloride in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2013) 0.88
Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains. Int J Pharm (2007) 0.87
Isolation, characterization, and plasmid pUPI126-mediated indole-3-acetic acid production in acinetobacter strains from rhizosphere of wheat. Appl Biochem Biotechnol (2002) 0.87
Chemical and biological metal nanoparticles as antimycobacterial agents: A comparative study. Int J Antimicrob Agents (2015) 0.86
Dual drug conjugated nanoparticle for simultaneous targeting of mitochondria and nucleus in cancer cells. ACS Appl Mater Interfaces (2015) 0.86
Enhancement of antibacterial activity of tilmicosin against Staphylococcus aureus by solid lipid nanoparticles in vitro and in vivo. Vet J (2011) 0.86
Assessment of 16S rRNA gene-based phylogenetic diversity and promising plant growth-promoting traits of Acinetobacter community from the rhizosphere of wheat. Microbiol Res (2010) 0.86
Metal resistance in Acinetobacter and its relation to beta-lactamase production. Biometals (1993) 0.86
Novel polyhedral gold nanoparticles: green synthesis, optimization and characterization by environmental isolate of Acinetobacter sp. SW30. World J Microbiol Biotechnol (2014) 0.86
Investigating effect of microemulsion components: In vitro permeation of ketoconazole. Pharm Dev Technol (2010) 0.85
Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study. Int J Antimicrob Agents (2006) 0.85
Novel lytic bacteriophage AB7-IBB1 of Acinetobacter baumannii: isolation, characterization and its effect on biofilm. Arch Virol (2012) 0.84
Inhibition of Acinetobacter baumannii biofilm formation on a methacrylate polymer containing a 2-aminoimidazole subunit. Chem Commun (Camb) (2011) 0.83
Antimicrobial properties of brevinin-2-related peptide and its analogs: Efficacy against multidrug-resistant Acinetobacter baumannii. Chem Biol Drug Des (2009) 0.83
Effect of a novel podophage AB7-IBB2 on Acinetobacter baumannii biofilm. Curr Microbiol (2012) 0.82
Time dependent enhanced resistance against antibiotics & metal salts by planktonic & biofilm form of Acinetobacter haemolyticus MMC 8 clinical isolate. Indian J Med Res (2014) 0.82
ZnO Nanoparticles-Red Sandalwood Conjugate: A Promising Anti-Diabetic Agent. J Nanosci Nanotechnol (2015) 0.82
Rapid evolution of silver nanoparticle resistance in Escherichia coli. Front Genet (2015) 0.81
Nylon-3 polymers active against drug-resistant Candida albicans biofilms. J Am Chem Soc (2015) 0.81